Numerous studies have been conducted examining the expression of, or mutations in, Daxx in tumor tissues, such as in oral cancer, pancreatic neuroendocrine tumors, urothelial carcinoma, prostate cancer, and ovarian cancer amongst others 8, 9, 10, 11, 12. This evidence concerns the gene DAXX and neoplasm.